| ankylosing spondylitis |
272 |
| enzyme-linked immunosorbent assay |
272 |
| gut microbiota |
272 |
| antirheumatic-agents |
279 |
| baricitinib |
279 |
| combination |
279 |
| monotherapy |
279 |
| rheumatoid arthritis |
279, 299, 308 |
| interleukin-1 inhibition |
288 |
| periodic fever syndromes |
288 |
| traps |
288 |
| tnfrsf1a gene |
288 |
| systemic autoinflammatory diseases |
288 |
| idiopathic pulmonary fibrosis |
299 |
| interstitial lung disease |
299, 308, 395 |
| saint george respiratory questionnaire |
299 |
| systemic sclerosis |
299, 308, 395 |
| warrick scoring system |
299 |
| ultrasonography |
308, 315 |
| psoriatic arthritis |
315 |
| rheumatic disease |
315 |
| sarcopenia |
315 |
| exosomes |
323 |
| gene chip |
323 |
| microrna |
323 |
| systemic lupus erythematosus |
323 |
| autoimmune diseases |
332 |
| disease burden |
332 |
| older adolescents |
332 |
| young adults |
332 |
| artificial intelligence |
358 |
| fibromyalgia |
358, 385 |
| health misinformation |
358 |
| supplementary resources |
358 |
| trends |
358 |
| arthritis |
365 |
| inflammatory rheumatic disorders |
365 |
| rheumatology |
365 |
| cally index |
376 |
| disease activity |
376 |
| halp score |
376 |
| immunonutritional biomarkers |
376 |
| primary sjögren’s syndrome |
376 |
| fear of movement |
385 |
| kinesiophobia |
385 |
| postural balance |
385 |
| women |
385 |
| network meta-analysis |
395 |
| pharmacological treatment |
395 |
